Study Design. A systematic review. Objective. The aim of this review was to evaluate the effectiveness of motor control exercise (MCE) in patients with nonspecific low back pain (LBP). Summary of Background Data. MCE is a common form of exercise used for managing LBP. MCE focuses on the activation of the deep trunk muscles and targets the restoration of control and coordination of these muscles, progressing to more complex and functional tasks integrating the activation of deep and global trunk muscles. Methods. We conducted electronic searches of CENTRAL, MEDLINE, EMBASE, five other databases, and two trials registers from their inception up to April 2015. Two independent review authors screened the search results, assessed risk of bias, and extracted the data. A third reviewer resolved any disagreement.
muscles.
1,2 MCE focuses on the activation of the deep spine muscles (i.e., transversus abdominis and multifidus), targeting the restoration of control and coordination of these muscles. 3, 4 During the intervention, patients are taught how to isolate the deep spinal muscles while maintaining normal respiration. The advanced stage of the intervention includes the progression toward more complex and functional tasks integrating the activation of deep and global trunk muscles. 3, 5, 6 Over the past two decades, the number of studies evaluating MCE for nonspecific LBP has increased, in line with its popularity in clinical practice. We are aware of recent trials not included in previous systematic reviews. 7, 8 In addition, the previous systematic reviews were not conducted to the standards of the Cochrane Collaboration. Thus, a well-conducted systematic review is important to provide accurate and robust information on the effectiveness of MCE to better inform clinicians, patients, and policy-makers. This is a copublication of two Cochrane reviews evaluating the effectiveness of MCE for patients with acute, subacute, and chronic nonspecific LBP.
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MATERIALS AND METHODS
Data Sources and Searches
We performed a computerized electronic search of the following databases: CENTRAL (up to issue 3, 2015) , MEDLINE (1946 . We used the search strategies developed by the Cochrane Back and Neck Review Group without restrictions on language or date of publication. The full electronic search for the MEDLINE database is presented in appendix 1, http://links.lww.com/BRS/B155. We also searched for registered trial protocols in the World Health Organization International Clinical Trials Registry Platform (WHO ICTRP), and ClinicalTrials.gov. We performed citation tracking using Web of Science (Thomson Reuters) and scanned the reference lists from previous reviews and eligible trials.
Two pairs of review authors independently screened titles, abstracts, and full-text articles for potentially eligible studies. Disagreements were resolved through discussion or by the arbitration of a third review author.
Study Selection
We only included randomized controlled trials (RCTs) and did not include trials with quasi-random allocation procedures. We included studies that enrolled adult participants with acute, subacute, or chronic nonspecific LBP (with or without leg pain). We excluded studies that included individuals with specific conditions such as disc herniation, spinal stenosis, and cancer.
We included trials comparing MCE with placebo, no treatment, another active treatment, or when MCE was added as a supplement to other interventions. We considered the intervention as MCE if the exercise was described as motor control or specific stabilization, and/ or exercise aiming to activate, train, or restore the function of specific muscles of the spine (i.e., multifidus and transversus abdominis). We also considered specific stabilization exercises and exercises aiming to activate, train, or restore the stabilization or coordination of specific deep muscles, as these principles integrate the MCE intervention. We did not include generalized (whole body) stability exercises. We did not include Pilates exercise in this review as a Cochrane review of Pilates was recently published, 11 although the principles of Pilates may overlap with the principles of MCE.
The primary outcomes of this review were pain intensity (e.g., Visual Analogue Scale, Numerical Rating Scale) and disability (e.g., Roland Morris Disability Questionnaire, Oswestry Disability Index). The secondary outcomes considered were function (e.g., Patient-Specific Functional Scale), quality of life (e.g., SF-36), global impression of recovery, return to work, adverse events, and recurrence.
Data Extraction and Quality Assessment
The data extraction from the eligible trials was performed using a standardized data extraction form containing (i) bibliometric data (authors, year of publication, language); (ii) study characteristics (study design, sample size, description of the sample, country, recruitment modality, funding); (iii) characteristics of the participants (gender, age, duration of symptoms, severity of the condition at baseline); (iv) description of the interventions (both experimental and control interventions), including dose (number of sessions, duration of each session of treatment, etc.) and cointerventions; (v) duration of follow-up assessments; (vi) outcomes assessed; (vii) study results (means, standards derivations, and sample sizes); and (viii) time periods for outcome assessment: short (less than three months after randomization), intermediate (at least three months but less than 12 months after randomization), and long term (12 months or more after randomization) follow-ups. When the studies did not provide enough information for the analysis, we contacted the authors to request additional data, or calculated or estimated the data using the recommendations of the Cochrane Handbook. 12 Two independent review authors extracted all data. We resolved disagreements through discussion or arbitration by a third review author.
The assessment of risk of bias was performed using the risk of bias assessment tool as recommended by The Cochrane Collaboration 12 and the Cochrane Back and Neck Review Group. 13 Two independent reviewers performed the risk of bias assessment and possible disagreements between them were resolved by discussion or arbitration by a third reviewer when consensus could not be reached. We did not consider the assessor blinded when patients were not blinded, as primary outcomes are self-report.
Data Synthesis and Analysis
We expressed pooled effects of continuous variables as mean differences (MDs) and 95% confidence intervals (CIs). To allow for continuous outcomes that used different scales, we converted the outcomes to a common 0 to 100 scale and expressed effect sizes as MDs and 95% CIs. For dichotomous outcomes, we used risk ratios (RRs) and 95% CIs to calculate treatment effects. For the interpretation of effect sizes, we defined three levels: small effect size (MD <10% of the scale], medium effect size (MD 10-20% of the scale), or large effect size (MD >20% of the scale), and a clinically important effect was considered when the magnitude of the effect size was at least medium (>10% of the scale).
We conducted the meta-analyses using random-effect models for short-term (less than three months after randomization), intermediate-term (at least three months but less than 12 months after randomization), and long-term followups (12 months or more after randomization). We used intention-to-treat analyses preferably over per-protocol (as-treated) analyses. The assessment of heterogeneity was based upon visual inspections of the plots and using the Chisquare test and I 2 statistic as recommended by the Cochrane Handbook. 12 The overall quality of the evidence was assessed using the GRADE approach. The quality of the evidence was based upon five domains: (1) study design and risk of bias (downgraded if > 25% of the participants were from studies with a high risk of bias); (2) inconsistency of results (downgraded if significant heterogeneity was presented by visual inspection or I 2 > 50%); (3) indirectness (generalizability of the findings; downgraded if >50% of the participants were outside the target group); (4) imprecision (downgraded if fewer than 400 participants were included in the comparison for continuous data and there were fewer than 300 events for dichotomous data; 14 and (5) other (i.e., publication bias). We reduced the quality of evidence by one level for each domain not met in the comparison. We described the quality of the evidence as follows: 15 High-quality evidence: there are consistent findings among at least 75% of RCTs with no limitations of the study design, consistent, direct, and precise data and no known or suspected publication biases. We are very confident that the true effect lies close to that of the estimate of the effect. Moderate-quality evidence: one of the domains is not met. We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different. Low-quality evidence: two of the domains are not met. Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.
Very low quality evidence: three of the domains are not met. We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. No evidence: no RCTs were identified that addressed this outcome.
We also performed sensitivity analyses to assess the influence of risk of bias on the overall estimates of effects for the primary outcomes (pain and disability). We defined high-quality trials for trials that fulfilled six or more of the risk of bias criteria.
RESULTS
The searches retrieved 2055 records, of which 181 full-text articles were assessed and a total of 32 trials (37 records) fulfilled the inclusion criteria. We included 29 trials evaluating patients with chronic LBP (n ¼ 2431), and three trials including patients with acute LBP (n ¼ 197). We did not find any trial including patients with subacute LBP. The trials included predominantly middle-aged participants recruited from primary or tertiary care. Details of the included trials can be assessed elsewhere.
9,10 Figure 1 shows the flowchart of the inclusion process of this review. Table 1 provides the summary of findings and quality of evidence for all comparisons and outcomes included in this review.
For the trials including chronic LBP patients, 16 trials compared MCE with other types of exercises (i.e., general or conventional exercises, stretching, strengthening exercises, graded activity, McKenzie). 6,7,16 -29 Seven trials compared MCE with minimal intervention, which included a placebo physiotherapy intervention, 5 education or advice, [30] [31] [32] and no treatment. [33] [34] [35] Five trials compared MCE with manual therapy, 6, 8, 18, 30, 36 and three trials compared MCE with a combination of exercise and electrophysical agents (EPAs) that included the use of ultrasound, short-wave diathermy and strengthening exercises in two trials, 37, 38 and heat and active stretching in other trial. 39 Finally, one trial compared MCE with telerehabilitation on the basis of home exercises with phone calls twice a week. 40 The duration of the treatment programs ranged from 20 days to 12 weeks [median (interquartile range, IQR) ¼ 8 (2.0) weeks], and the number of sessions per week ranging from one to five.
For trials including acute LBP patients, two trials compared MCE with other types of exercise (i.e., general exercise and specific exercise). 41, 42 One trial also compared MCE with spinal manipulative therapy, 42 and one trial
For chronic LBP, a total of 76.6% of the included trials had a low risk of bias, representing 86% of all participants (n ¼ 2088). The overall risk of bias scores varied from 3 to 11, with a mean (standard deviation) of 6.8 (1.93). For the acute trials, two were considered as having a low risk of bias 41, 42 and one trial as having a high risk of bias. 43 Details of the risk of bias assessment have been described elsewhere.
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Analysis Effect of Motor Control Exercise Versus Other Exercises: Chronic LBP There is low-quality evidence that there is a small, but not clinically important effect of MCE for reducing pain intensity at short-term follow-up (MD À7.53; 95% CI À10.54 to À4.52, 13 trials), and high-quality evidence that there is no clinically important effect for pain at intermediate (MD À2.98; 95% CI À6.96 to 0.99, 6 trials) and long-term follow-ups (MD À2.69; 95% CI À6.90 to 1.53, five trials) ( Figure 2 ). For disability, there is low-quality evidence that there is a small, but not clinically important effect at shortterm follow-up (MD À4.82; 95% CI À6.95 to À2.68, 11 trials), and high-quality evidence for no clinically important effect at intermediate (MD À2.88; 95% CI À6.92 to 1.15, 10 trials) and long-term follow-up (MD À0.71; 95%CI À4.87 to 3.45, four trials).
For the secondary outcomes, there is moderate-quality evidence that there is a small, but not clinically important effect of MCE for improving function at short term, and no clinically important effect for intermediate and long-term follow-ups, with low-quality evidence for long term. For global impression of recovery, there is moderate-quality evidence that there is no clinically important effect at intermediate and long-term follow-ups. Results for short-term follow-up were not pooled due to high heterogeneity. For the physical component of quality of life, there is low-quality evidence that there is no clinically important effect at short and intermediate-term follow-up and moderate-quality evidence that there is no clinically important effect at long-term 
Very low
All effect sizes were expressed as mean difference, except for recurrence that was expressed as risk ratio. Pain, disability, and quality of life outcomes were measured in a 0 to 100 scale. Function and global impression of recovery outcomes were measured in a 0 to 10 scale. For pain and disability outcomes, a negative effect size represents an effect in favor of MCE. For function, global impression of recovery, and quality of life outcomes, a positive effect size value represents an effect in favor of MCE. Ã Clinically important effect. 
Effect of Motor Control Exercise Versus Manual Therapy:
Chronic LBP There is moderate-quality evidence that there is no clinically important effect for pain intensity at short (MD À4.36; 95% For the secondary outcomes, there is low-quality evidence that there are no clinically important effects for function and global impression of recovery, based on one trial. No adverse events were reported.
Acute LBP On the basis of one trial, 42 there is low-quality evidence that there is no clinically important effect for pain at short term (MD 9.00, 95% CI À1.56 to 19.56) or for disability at short term (MD 4.00, 95% CI À3.38 to 11.38) and long term (MD 3.70, 95% CI À4.10 to 11.50).
Effect of Motor Control Exercise Versus Minimal
Intervention: Chronic LBP There is moderate-quality evidence that there is a clinically important effect of MCE for reducing pain with medium effect size at short-term (MD À10.01; 95% CI À15.67 to À4.35, four trials) and long-term follow-up (MD À12.97; 95% CI À18.51 to À7.42, three trials). There is low-quality evidence for a clinically important effect in favor of MCE at intermediate term, with a medium effect size (MD À12.61; 95% CI À20.53 to À4.69, four trials) (Figure 3 ). For disability, there is very low quality evidence of a small, but not clinically important effect at short-term follow-up (MD À8.63; 95% CI À14.78 to À2.47, five trials), and moderate-quality evidence that there is a small but not clinically important effect at intermediate (MD À5.47; 95% CI À9.17 to À1.77, four trials) and long-term follow-up (MD À5.96; 95% CI À9.81 to À2.11, three trials) (Figure 4) .
For the secondary outcomes, there is low-quality evidence of a clinically important effect of MCE for improving function and global impression of recovery with medium effect size at all time periods. One trial 5 reported mild adverse events for both groups during the study period.
Effect of Motor Control Exercise Versus Combination of Exercise and Electrophysical Agents (EPAs): Chronic LBP
There is low-quality evidence of a clinically important effect for reducing pain at short term, with a large effect size (MD À30.18; 95% CI À35.32 to À25.05, two trials). We did not pool results for intermediate term due to high heterogeneity. For disability, there is very low quality evidence of a clinically important effect in favor of MCE at short term, with large effect size (MD À20.83; 95% CI À28.07 to À13.59, Figure 3 . Forest plot of the comparison between MCE versus minimal intervention for the outcome pain.
one trial) and low-quality evidence for intermediate term, with medium effect size (MD À11.50; 95% CI À20.69 to À2.31, one trial).
For the secondary outcomes, there is low-quality evidence of a clinically important effect in favor of MCE for global impression of recovery at short and intermediate term with medium effect sizes. For the physical component of quality of life, there is low-quality evidence of a small, but not clinically important effect at short and intermediate term. For the mental component of quality of life, there is low-quality evidence of no clinically important effect at short and intermediate term. One trial 37 evaluated adverse events, but none were reported.
Effect of Motor Control Exercise Versus
Telerehabilitation: Chronic LBP There is very low quality evidence that there is no clinically important effect at intermediate term for pain intensity (MD À10.00; 95% CI À32.35 to 12.35, one trial), and disability (MD 12.50; 95% CI À16.38 to 41.38, one trial), or for the metal and physical component of quality of life.
Effect of Motor Control Exercise as a Supplement to
Medical Management: Acute LBP There is very low quality evidence that there are no clinically important differences in outcome from adding MCE to medical management for pain at short-term (MD À9.30; 95% CI À20.41 to 1.81, one trial), and disability short-term (MD À0.90, 95% CI À4.77 to 2.97, one trial). For recurrence at one year, there is very low quality evidence suggesting that adding MCE to medical management decreases the risk of recurrence by 64% compared with medical management alone (RR 0.36, 95% CI 0.18-0.72, one trial). 43 
DISCUSSION
In this review, we did not find clinically important differences for any outcomes evaluated between MCE and other forms of exercise or manual therapy for both acute and chronic LBP, with varied quality of evidence (very low to high) in these comparisons. For chronic LBP, we found low to moderatequality evidence that there is a clinically important effect of MCE for reducing pain compared with minimal intervention at all follow-up periods; however, only small and not clinically important effects were found for disability with very low to moderate-quality evidence. There was a clinically important effect with low-quality evidence for all secondary outcomes in this comparison. For the comparison of MCE against exercise and EPA for chronic LBP, there was very low to low-quality evidence that there is a clinically important difference for pain and disability, and the secondary outcomes, except for the mental component of quality of life. There were no clinically important differences between MCE and telerehabilitation for pain, disability, or quality of life with very low quality of evidence. Finally, very low quality evidence suggests that MCE and medical management decrease the risk of recurrence compared with medical management alone. These results were also consistent with the sensitivity analyses on risk of bias.
The findings from the previous systematic reviews of MCE for persistent LBP are consistent with our results. Two previous reviews also reported a clinically important effect of MCE compared with minimal intervention. 45, 46 These reviews also reported no clinically important differences between MCE and other types of exercises for pain intensity. [45] [46] [47] However, Bystrom et al. 45 and Wang et al. 47 reported a statistically significant effect on disability favoring MCE compared with general exercise, which we did not find in this review. This divergence may be explained because these reviews included fewer trials and only considered general exercise in the exercise group, while we considered all types of exercises other than MCE. When comparing MCE with manual therapy, the previous reviews did not find an effect of MCE or reported small effect sizes, which was not considered clinically important in this review. 45, 46 The review from Bystrom et al. 45 compared MCE with multimodal physical therapy for chronic LBP, which is similar to our comparison of MCE versus exercise and EPA, and our results are similar. However, these results were unexpected, as we did not expect effects to be much greater than MCE versus minimal intervention. It is likely that these results might be explained by the small sample sizes and limitations in the trials' designs, as we found that very low to low-quality evidence indicates that the true effect may be or is very likely to be substantially different from the estimate of the effect. Results for acute LBP are consistent with the findings of other reviews and clinical practice guidelines in concluding that exercise is not recommended for treating an episode of acute LBP. 48, 49 For recurrence at one year, MCE added to medical management decreased the risk of recurrence, this finding is consistent with a previous review 50 ; however, we found very low quality evidence, limiting our confidence in this result.
A limitation of this review is the presence of publication bias as reported elsewhere. 10 However, for most comparisons, it was not possible to assess publication bias using funnel plots, as too few studies were included; thus, we did not downgrade the GRADE score for the publication bias criterion. We do not have data from three conference abstracts, as all attempts to contact the authors regarding the full-text article were unsuccessful; thus, this may also potentially indicate publication bias. In addition, it was unclear how much care was taken in implementing both the comparison treatments and MCE in the included studies, as most of the treatment protocols were very briefly described. This also prevents us from performing a sensitivity analysis between stricter and broader definitions of MCE and other interventions. The distinction between MCE, specific spinal stabilization exercise, and stabilization exercise is subtle, and development and adoption of consensus terms and operational definitions for these forms of therapeutic exercise could facilitate improved understanding among care providers in this field.
Future RCTs in chronic nonspecific LBP should include more complete descriptions of the exercise interventions so that interpretation of the results would be facilitated. We strongly recommend that future trials have adequate sample size, as most of the trials in this review are considered small (fewer than 50 participants). Trials including cost-effectiveness analysis and long-term outcomes are also needed in this area. The effectiveness of MCE should also be tested in target groups, such as subgroups of patients more likely to respond to this treatment approach. 51 The role of exercise in preventing recurrence of acute back pain should also be investigated in future research.
CONCLUSION
MCE is probably more effective than a minimal intervention for reducing pain, but probably does not have an important effect on disability, in patients with chronic LBP. We did not find a clinically important difference between MCE and other forms of exercises or manual therapy for acute and chronic LBP. We are uncertain about the effectiveness of MCE compared with exercise and EPA, as we considered the quality of the evidence low or very low. It is unclear whether MCE can prevent recurrences of LBP because available evidence is of very low quality. As MCE appears to be a safe form of exercise and none of the other types of exercise stands out, the choice of exercise for chronic LBP should depend on patient or therapist preferences, therapist training, costs, and safety.
Key Points
Motor control exercise seems to be more effective than a minimal intervention for reducing pain, but does not have an important effect on disability, in patients with chronic LBP. There is no clinically important difference between motor control exercise and other forms of exercises or manual therapy for acute and chronic LBP. The choice of exercise for chronic LBP should depend on patient or therapist preferences, therapist training, costs, and safety. We are uncertain about the effectiveness of MCE compared with exercise and EPA, as the quality of the evidence is low or very low. It is unclear whether motor control exercise can prevent recurrences of low back pain because the evidence was of very low quality.
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